Lifetime prognosis of juvenile myoclonic epilepsy

Epilepsy and Behavior

Volumn 28, Issue 1, 2013, Pages

  Baykan, Betul ^a   Martínez Juárez, Iris E ^b   Altindag, Ebru A ^c   Camfield, Carol S ^d   Camfield, Peter R ^d  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c ISTANBUL BILIM UNIVERSITY   (Turkey)

^d IWK HEALTH CENTRE   (Canada)

Author keywords

Epidemiology; Juvenile myoclonic epilepsy; Long term follow up; Population based studies; Prognosis; Remission; Status epilepticus; Subsyndromes; SUDEP; Therapy resistance

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; TOPIRAMATE; VALPROIC ACID;

ANTICONVULSANT THERAPY; BENIGN CHILDHOOD EPILEPSY; COHORT ANALYSIS; DISEASE SEVERITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; EVIDENCE BASED MEDICINE; FOCAL EPILEPSY; FOLLOW UP; GENERALIZED TONIC CLONIC SEIZURE; HUMAN; INTRACTABLE EPILEPSY; LIKERT SCALE; LONG TERM CARE; MEDICAL HISTORY; MENTAL DISEASE; MYOCLONUS EPILEPSY; NEUROIMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERSONALITY DISORDER; PREVALENCE; PROGNOSIS; REMISSION; REVIEW; RISK FACTOR; SEIZURE; SPIKE WAVE; TEMPORAL LOBE EPILEPSY; THYROID DISEASE; TONIC CLONIC SEIZURE;

EID: 84878994266     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.06.036     Document Type: Review

References (77)

1. Panayiotopoulos C.P., Obeid T., Tahan A.R. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia 1994, 35(2):285-296.
2. Camfield C.S., Camfield P.R. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology 2009, 73(13):1041-1045.
3. Baykan B., Altindag E.A., Bebek N., et al. Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy. Neurology 2008, 70(22):2123-2129.
4. Öztürk A., Baykan B., Gürses C., Gökyigit A. Long-term follow-up of juvenile myoclonic epilepsy. Archives of Neuropsychiatry (Noropsikiyatri Arşivi) 1999, 36(3):123-127.
5. Baykan-Kurt B., Gökyigit A., Çaliskan A. Juvenile myoclonic epilepsy. Archives of Neuropsychiatry (Noropsikiyatri Arşivi) 1991, 28(1):41-48.
6. Martinez-Juarez I.E., Alonso M.E., Medina M.T., et al. Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain 2006, 129(5):1269-1280.
7. Siren A., Eriksson K., Jalava H., et al. Idiopathic generalised epilepsies with 3Hz and faster spike wave discharge: a population-based study with evaluation and long-term follow-up in 71 patients. Epileptic Disord 2002, 4:209-216.
8. Geerts A., Arts W.F., Stroink H., et al. Course and outcome of childhood epilepsy: a 15-year follow-up of the Dutch Study of Epilepsy in Childhood. Epilepsia 2010, 51:1189-1197.
9. Loddenkemper T., Benbadis S.R., Serrasota J.M., Berkovic S.F. Idiopathic generalized epilepsy syndromes of childhood and adolescence. The treatment of epilepsy. Principles and practice 2006, 296. Lippincott Williams & Wilkins, Philadelphia. E. Wyllie (Ed.).
10. Gelisse P., Genton P., Thomas P., Rey M., Samuelian J.C., Dravet C. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 2001, 70(2):240-243.
11. Guaranha M.S., Filho G.M., Lin K., Guilhoto L.M., Caboclo L.O., Yacubian E.M. Prognosis of juvenile myoclonic epilepsy is related to endophenotypes. Seizure 2011, 20(1):42-48.
12. Jain S., Padma M.V., Maheshwari M.C. Occurrence of only myoclonic jerks in juvenile myoclonic epilepsy. Acta Neurol Scand 1997, 95(5):263-267.
13. Matsuoka H. The seizure prognosis of juvenile myoclonic epilepsy. Jpn J Psychiatry Neurol 1992, 46(2):293-296.
14. Moschetta S., Fiore L.A., Fuentes D., Gois J., Valente K.D. Personality traits in patients with juvenile myoclonic epilepsy. Epilepsy Behav 2011, 21(4):473-477.
15. de Araújo Filho G.M., Pascalicchio T.F., Sousa Pda S., Lin K., Ferreira Guilhoto L.M., Yacubian E.M. Psychiatric disorders in juvenile myoclonic epilepsy: a controlled study of 100 patients. Epilepsy Behav 2007, 10(3):437-441.
16. Su Y.H., Izumi T., Kitsu M., Fukuyama Y. Seizure threshold in juvenile myoclonic epilepsy with Graves disease. Epilepsia 1993, 34(3):488-492.
17. Obeid T., Awada A., al Rajeh S., Chaballout A. Thyroxine exacerbates absence seizures in juvenile myoclonic epilepsy. Neurology 1996, 47(2):605-606.
18. Dasheiff R.M., Ritaccio A.L. Characterization of intractable juvenile myoclonic epilepsy: new perspectives on primarily generalized seizures. Seizure 1993, 2(1):11-19.
19. Atakli D., Sözüer D., Atay T., Baybas S., Arpaci B. Misdiagnosis and treatment in juvenile myoclonic epilepsy. Seizure 1998, 7(1):63-66.
20. Grünewald R.A., Chroni E., Panayiotopoulos C.P. Delayed diagnosis of juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 1992, 55(6):497-499.
21. Taylor I., Marini C., Johnson M.R., Tuner S., Berkovic S.F., Scheffer I.E. Juvenile myoclonic epilepsy and idiopathic photosensitive occipital lobe epilepsy: is there overlap?. Brain 2004, 127(8):1878-1886.
22. Diehl B., Wyllie E., Rothner D., Bingaman W. Worsening seizures after surgery for focal epilepsy due to emergence of primary generalized epilepsy. Neurology 1998, 51(4):1178-1180.
23. Koutroumanidis M., Hennessy M.J., Elwes R.D., Binnie C.D., Polkey C.E. Coexistence of temporal lobe and idiopathic generalized epilepsies. Neurology 1999, 53(3):490-495.
24. Genton P., Gelisse P., Thomas P., Dravet C. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?. Neurology 2000, 55(8):1106-1109.
25. Knott C., Panayiotopoulos C.P. Carbamazepine in the treatment of generalised tonic clonic seizures in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 1994, 57(4):503.
26. Carrazana E.J., Wheeler S.D. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 2001, 56(10):1424-1425.
27. Bodenstein-Sachar H., Gandelman-Marton R., Ben-Zeev B., Chapman J., Blatt I. Outcome of lamotrigine treatment in juvenile myoclonic epilepsy. Acta Neurol Scand 2011, 124(1):22-27.
28. Fernando-Dongas M.C., Radtke R.A., VanLandingham K.E., Husain A.M. Characteristics of valproic acid resistant juvenile myoclonic epilepsy. Seizure 2000, 9(6):385-388.
29. Usui N., Kotagal P., Matsumoto R., Kellinghaus C., Lüders H.O. Focal semiologic and electroencephalographic features in patients with juvenile myoclonic epilepsy. Epilepsia 2005, 46(10):1668-1676.
30. Aliberti V., Grünewald R.A., Panayiotopoulos C.P., Chroni E. Focal electroencephalographic abnormalities in juvenile myoclonic epilepsy. Epilepsia 1994, 35(2):297-301.
31. Lancman M.E., Asconape J.J., Penry J.K. Clinical and EEG asymmetries in juvenile myoclonic epilepsy. Epilepsia 1994, 35(2):302-306.
32. Lancman M.E., Asconape J.J., Golimstok A. Circling seizures in a case of juvenile myoclonic epilepsy. Epilepsia 1994, 35(2):317-318.
33. Panayiotopoulos C.P., Tahan R., Obeid T. Juvenile myoclonic epilepsy: factors of error involved in the diagnosis and treatment. Epilepsia 1991, 32(5):672-676.
34. Montalenti E., Imperiale D., Rovera A., Bergamasco B., Benna P. Clinical features, EEG findings and diagnostic pitfalls in juvenile myoclonic epilepsy: a series of 63 patients. J Neurol Sci 2001, 184(1):65-70.
35. Topcuoglu M.A., Saygi S., Ciger A. Rotatory seizures in juvenile myoclonic epilepsy. Clin Neurol Neurosurg 1997, 99(4):248-251.
36. So G.M., Thiele E.A., Sanger T., Schmid R., Riviello J.J. Electroencephalogram and clinical focalities in juvenile myoclonic epilepsy. J Child Neurol 1998, 13(11):541-545.
37. Jain S., Tripathi M., Srivastava A.K., Narula A. Phenotypic analysis of juvenile myoclonic epilepsy in Indian families. Acta Neurol Scand 2003, 107:356-362.
38. Appleton R.E., Panayiotopoulos C.P., Acomb B.A., Beirne M. Eyelid myoclonia with typical absences: an epilepsy syndrome. J Neurol Neurosurg Psychiatry 1993, 56(12):1312-1316.
39. Giannakodimos S., Panayiotopoulos C.P. Eyelid myoclonia with absences in adults: a clinical and video-EEG study. Epilepsia 1996, 37(1):36-44.
40. Striano S., Capovilla G., Sofia V., et al. Eyelid myoclonia with absences (Jeavons syndrome): a well-defined idiopathic generalized epilepsy syndrome or a spectrum of photosensitive conditions?. Epilepsia 2009, 50(Suppl. 5):15-19.
41. Baykan-Kurt B., Gökyiǧit A., Parman Y., Kinay D., Gürses C. Eye closure related spike and wave discharges: clinical and syndromic associations. Clin Electroencephalogr 1999, 30(3):106-110.
42. Sevgi E.B., Saygi S., Ciger A. Eye closure sensitivity and epileptic syndromes: a retrospective study of 26 adult cases. Seizure 2007, 16(1):17-21.
43. Destina Yalçin A., Forta H., Kiliç E. Overlap cases of eyelid myoclonia with absences and juvenile myoclonic epilepsy. Seizure 2006, 15(6):359-365.
44. Gelisse P., Genton P., Raybaud C., Thomas P., Dravet C. Structural brain lesions do not influence the prognosis of juvenile myoclonic epilepsy. Acta Neurol Scand 2000, 102(3):188-191.
45. Aslan K., Bozdemir H., Yapar Z., Burgut R. The effect of electrophysiological and neuroimaging findings on the prognosis of juvenile myoclonic epilepsy proband. Neurol Res 2010, 32(6):620-624.
46. Anderson J., Hamandi K. Understanding juvenile myoclonic epilepsy: contributions from neuroimaging. Epilepsy Res 2011, 94:127-137.
47. Janz D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). Acta Neurol Scand 1985, 72(5):449-459.
48. Alonso M.E., Medina M.T., Martínez-Juárez I.E., et al. Familial juvenile myoclonic epilepsy. Adv Neurol 2005, 95:227-243.
49. Medina M.T., Martínez-Juárez I.E., Durón R.M., et al. Treatment of myoclonic epilepsies of childhood, adolescence and adulthood. Adv Neurol 2005, 95:307-323.
50. Herpin T. Des acces incomplets d'epilepsie 1867, Bailliere, Paris.
51. Rabot L. De la myoclonie e'pileptique. Medical thesis. Paris; 1899.
52. Janz D., Christian W. Impulsive-petit mal. Dtsch Z Nervenheilkd 1957, 176:344-386.
53. Wirrell E.C., Camfield P.R., Camfield P.R., Gordon K.E., Dooley J.M. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology 1996, 47:912-918.
54. Moore T., Hecquet S., McLellann A., et al. Polymorphism analysis of JRK/JH8, the human homologue of mouse jerky, and description of a rare mutation in a case of CAE evolving to JME. Epilepsy Res 2001, 46:157-167.
55. Durón R.M., Medina M.T., Martínez-Juárez I.E., et al. Seizures of idiopathic generalized epilepsies. Epilepsia 2005, 46(Suppl. 9):34-47.
56. Asconape J., Penry J.K. Some clinical and EEG aspects of benign juvenile myoclonic epilepsy. Epilepsia 1984, 25(1):108-114.
57. Delgado-Escueta A.V., Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology 1984, 34(3):285-294.
58. Panayiotopoulos C.P., Obeid T., Waheed G. Absences in juvenile myoclonic epilepsy: a clinical and video-electroencephalographic study. Ann Neurol 1989, 25(4):391-397.
59. Matsuoka H., Takahashi T., Sasaki M., Yoshida S., Numachi Y., Sato M. The long-term course of seizure susceptibility in two patients with juvenile myoclonic epilepsy. Seizure 2002, 11(2):126-130.
60. Magaudda A., Ferlazzo E., Nguyen V.H., Genton P. Unverricht-Lundborg disease, a condition with self-limited progression: long-term follow-up of 20 patients. Epilepsia 2006, 47(5):860-866.
61. Gram L., Alving J., Sagild J.C., Dam M. Juvenile myoclonic epilepsy in unexpected age groups. Epilepsy Res 1988, 2(2):137-140.
62. Grünewald R.A., Panayiotopoulos C.P. Diagnosing juvenile myoclonic epilepsy in an elderly patient. Seizure 1994, 3(3):239-241.
63. Jacob S., Martin D., Rajabally Y.A. Juvenile myoclonic epilepsy in an elderly patient. Age Ageing 2006, 35(2):194-196.
64. Dziewas R., Kellinghaus C., Lüdemann P. Nonconvulsive status epilepticus in patients with juvenile myoclonic epilepsy: types and frequencies. Seizure 2002, 11:335-339.
65. Agathonikou A., Panayiotopoulos C.P., Giannakodimos S., Koutroumanidis M. Typical absence status in adults: diagnostic and syndromic considerations. Epilepsia 1998, 39:1265-1276.
66. Tomson T., Lindborn U., Nilsson B.Y. Nonconvulsive status epilepticus in adults: thirty-two consecutive patients from a general hospital population. Epilepsia 1992, 33:829-835.
67. Baykan B., Gökyigit A., Gurses C., Eraksoy M. Recurrent absence status epilepticus: clinical and EEG characteristics. Seizure 2002, 11:310-319.
68. Walker M., Cross H., Smith S., et al. Nonconvulsive status epilepticus: Epilepsy Research Foundation Workshop Reports. Epileptic Disord 2005, 7:253-296.
69. Badhwar A., Siren A., Andermann E., Andermann F. Myoclonic status epilepticus: video presentation. Mov Disord 2002, 17:409-411.
70. Terzano M.G., Gemignani F., Mancia D. Petit mal status with myoclonus: case report. Epilepsia 1978, 19:385-392.
71. Grüneberg F., Helmchen E. Impulsive petit mal status and paranoid psychosis. Nervenarzt 1969, 40:381-385.
72. van Leeuwen S.W., Jennekens F., Sterk C.E. A case of petit mal status with myoclonus. Epilepsia 1969, 10:407-414.
73. Schneeman N., Brune F., Busch H. Impulsive petit mal and twilight state, an unusual combination of epileptic phenomena. Schweiz Arch Neurol Neurochir Psychiatr 1969, 105:281-292.
74. Larch J., Unterberger I., Bauer G., Reichsoellner J., Kuchukhidze G., Trinka E. Myoclonic status epilepticus in juvenile myoclonic epilepsy. Epileptic Disord 2009, 11:309-314.
75. Thomas P., Valton L., Genton P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 2006, 129:1281-1292.
76. Trinka E., Dilitz E., Unterberger I., et al. Nonconvulsive status epilepticus after replacement of valproate with lamotrigine. J Neurol 2002, 249:1417-1422.
77. Trinka E. Valproate and newer antiepileptic drugs for status epilepticus. Epilepsia 2007, 48(Suppl. 8):49-51.